Tassin la Demi Lune, France

Catherine Gerdil

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sanofi Pasteur Sa. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Gerdil. Retrieved from https://idiyas.com/inventor/catherine-gerdil-4wkw7v4t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine Gerdil

Introduction

Catherine Gerdil is a notable inventor based in Tassin la Demi Lune, France. She has made significant contributions to the field of virology, particularly in the production of the flu virus. Her innovative approach has garnered attention in the scientific community.

Latest Patents

Catherine Gerdil holds a patent for a method of producing the flu virus. This invention outlines a novel technique that enhances the efficiency of flu virus production, which is crucial for vaccine development and public health.

Career Highlights

Throughout her career, Gerdil has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur SA and Sanofi Pasteur Inc. Her experience in these organizations has allowed her to contribute to significant advancements in vaccine technology.

Collaborations

Catherine Gerdil has collaborated with esteemed colleagues, including Catherine Moste and Isabelle Legastelois. These partnerships have fostered a collaborative environment that promotes innovation and research in virology.

Conclusion

Catherine Gerdil's work exemplifies the impact of innovative thinking in the field of virology. Her contributions, particularly in the production of the flu virus, highlight the importance of research and collaboration in advancing public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…